Fertility Preservation for Transgender Individuals: A Review
Transgender individuals represent a small, albeit growing, patient population that is encountered more frequently in clinical care due to improved insurance coverage and increasing awareness. Gender-affirming treatments, including both gender-affirming hormone therapy and gender-affirming surgery, p...
Gespeichert in:
| Veröffentlicht in: | Mayo Clinic proceedings 2020-04, Vol.95 (4), p.784-792 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 792 |
|---|---|
| container_issue | 4 |
| container_start_page | 784 |
| container_title | Mayo Clinic proceedings |
| container_volume | 95 |
| creator | Ainsworth, Alessandra J Allyse, Megan Khan, Zaraq |
| description | Transgender individuals represent a small, albeit growing, patient population that is encountered more frequently in clinical care due to improved insurance coverage and increasing awareness. Gender-affirming treatments, including both gender-affirming hormone therapy and gender-affirming surgery, pose significant risks to fertility potential and outcomes, ranging from potentially impaired fertility rates to full elimination of reproductive potential depending on the type of treatment pursued. However, there are relatively limited data specific to fertility preservation for transgender individuals. Current approaches to treatment are extrapolated from options for fertility preservation after oncologic diagnoses. In this review, we aim to summarize current clinical approaches, fertility preservation options, and patient experiences in fertility preservation for transgender individuals. Several forms of fertility preservation options are available depending on the pubertal status of a transgender individual. Despite the multiple options for fertility preservation, major barriers exist to patient care and there are reports of mixed patient experiences. Further awareness of this clinical situation and understanding of these processes will allow for comprehensive and specialized care for transgender individuals who may otherwise miss opportunities for adequate counseling or treatment options regarding fertility preservation. |
| doi_str_mv | 10.1016/j.mayocp.2019.10.040 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2369876328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A623573481</galeid><sourcerecordid>A623573481</sourcerecordid><originalsourceid>FETCH-LOGICAL-g309t-a20b36b3d2965b8184abb319f3ddd2ca2398801c0be46321fe6b5f2da97aa9073</originalsourceid><addsrcrecordid>eNpdkF9LwzAUxYMoOqffQKQgiC-t-dOmifgyxKkwUGQ-l7S5nRltM5N2sm9vZBNU7sOFw-_cezgInRGcEEz49TJp1cZWq4RiIoOU4BTvoRGRKY2zLOX7aIQxzWJOJD9Cx94vMca5lOkhOmKUkIzIbIRup-B605h-E7048ODWqje2i2rrorlTnV9Ap8FFT502a6MH1fibaBK9wtrA5wk6qIMAp7s9Rm_T-_ndYzx7fni6m8ziBcOyjxXFJeMl01TyrBREpKosGZE101rTSlEmhcCkwiWkPESrgZdZTbWSuVIS52yMrrZ3V85-DOD7ojW-gqZRHdjBF5RxKfJgFQG9-Icu7eC6kC5QgksmsZCBSrbUQjVQmK62vVNVGA2tqWwHtQn6hFOW5SwVJBgufxneQTX9u7fN8N2V_wue7_4PZQu6WDnTKrcpfhpnX5pegfE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2386939089</pqid></control><display><type>article</type><title>Fertility Preservation for Transgender Individuals: A Review</title><source>Alma/SFX Local Collection</source><creator>Ainsworth, Alessandra J ; Allyse, Megan ; Khan, Zaraq</creator><creatorcontrib>Ainsworth, Alessandra J ; Allyse, Megan ; Khan, Zaraq</creatorcontrib><description>Transgender individuals represent a small, albeit growing, patient population that is encountered more frequently in clinical care due to improved insurance coverage and increasing awareness. Gender-affirming treatments, including both gender-affirming hormone therapy and gender-affirming surgery, pose significant risks to fertility potential and outcomes, ranging from potentially impaired fertility rates to full elimination of reproductive potential depending on the type of treatment pursued. However, there are relatively limited data specific to fertility preservation for transgender individuals. Current approaches to treatment are extrapolated from options for fertility preservation after oncologic diagnoses. In this review, we aim to summarize current clinical approaches, fertility preservation options, and patient experiences in fertility preservation for transgender individuals. Several forms of fertility preservation options are available depending on the pubertal status of a transgender individual. Despite the multiple options for fertility preservation, major barriers exist to patient care and there are reports of mixed patient experiences. Further awareness of this clinical situation and understanding of these processes will allow for comprehensive and specialized care for transgender individuals who may otherwise miss opportunities for adequate counseling or treatment options regarding fertility preservation.</description><identifier>ISSN: 0025-6196</identifier><identifier>EISSN: 1942-5546</identifier><identifier>DOI: 10.1016/j.mayocp.2019.10.040</identifier><identifier>PMID: 32115195</identifier><language>eng</language><publisher>England: Frontline Medical Communications Inc</publisher><subject>Cryopreservation ; Drug dosages ; Endocrine therapy ; Fertility ; Gender ; Gender identity ; Hormones ; In vitro fertilization ; Insurance ; International organizations ; Motility ; Patients ; Pregnancy ; Preservation ; Reproductive health ; Reproductive technologies ; Sperm ; Spermatogenesis ; Surgery ; Transgender people ; Transgender persons</subject><ispartof>Mayo Clinic proceedings, 2020-04, Vol.95 (4), p.784-792</ispartof><rights>Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.</rights><rights>COPYRIGHT 2020 Frontline Medical Communications Inc.</rights><rights>Copyright Mayo Foundation for Medical Education and Research Apr 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32115195$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ainsworth, Alessandra J</creatorcontrib><creatorcontrib>Allyse, Megan</creatorcontrib><creatorcontrib>Khan, Zaraq</creatorcontrib><title>Fertility Preservation for Transgender Individuals: A Review</title><title>Mayo Clinic proceedings</title><addtitle>Mayo Clin Proc</addtitle><description>Transgender individuals represent a small, albeit growing, patient population that is encountered more frequently in clinical care due to improved insurance coverage and increasing awareness. Gender-affirming treatments, including both gender-affirming hormone therapy and gender-affirming surgery, pose significant risks to fertility potential and outcomes, ranging from potentially impaired fertility rates to full elimination of reproductive potential depending on the type of treatment pursued. However, there are relatively limited data specific to fertility preservation for transgender individuals. Current approaches to treatment are extrapolated from options for fertility preservation after oncologic diagnoses. In this review, we aim to summarize current clinical approaches, fertility preservation options, and patient experiences in fertility preservation for transgender individuals. Several forms of fertility preservation options are available depending on the pubertal status of a transgender individual. Despite the multiple options for fertility preservation, major barriers exist to patient care and there are reports of mixed patient experiences. Further awareness of this clinical situation and understanding of these processes will allow for comprehensive and specialized care for transgender individuals who may otherwise miss opportunities for adequate counseling or treatment options regarding fertility preservation.</description><subject>Cryopreservation</subject><subject>Drug dosages</subject><subject>Endocrine therapy</subject><subject>Fertility</subject><subject>Gender</subject><subject>Gender identity</subject><subject>Hormones</subject><subject>In vitro fertilization</subject><subject>Insurance</subject><subject>International organizations</subject><subject>Motility</subject><subject>Patients</subject><subject>Pregnancy</subject><subject>Preservation</subject><subject>Reproductive health</subject><subject>Reproductive technologies</subject><subject>Sperm</subject><subject>Spermatogenesis</subject><subject>Surgery</subject><subject>Transgender people</subject><subject>Transgender persons</subject><issn>0025-6196</issn><issn>1942-5546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkF9LwzAUxYMoOqffQKQgiC-t-dOmifgyxKkwUGQ-l7S5nRltM5N2sm9vZBNU7sOFw-_cezgInRGcEEz49TJp1cZWq4RiIoOU4BTvoRGRKY2zLOX7aIQxzWJOJD9Cx94vMca5lOkhOmKUkIzIbIRup-B605h-E7048ODWqje2i2rrorlTnV9Ap8FFT502a6MH1fibaBK9wtrA5wk6qIMAp7s9Rm_T-_ndYzx7fni6m8ziBcOyjxXFJeMl01TyrBREpKosGZE101rTSlEmhcCkwiWkPESrgZdZTbWSuVIS52yMrrZ3V85-DOD7ojW-gqZRHdjBF5RxKfJgFQG9-Icu7eC6kC5QgksmsZCBSrbUQjVQmK62vVNVGA2tqWwHtQn6hFOW5SwVJBgufxneQTX9u7fN8N2V_wue7_4PZQu6WDnTKrcpfhpnX5pegfE</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Ainsworth, Alessandra J</creator><creator>Allyse, Megan</creator><creator>Khan, Zaraq</creator><general>Frontline Medical Communications Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>3V.</scope><scope>4U-</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>202004</creationdate><title>Fertility Preservation for Transgender Individuals: A Review</title><author>Ainsworth, Alessandra J ; Allyse, Megan ; Khan, Zaraq</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g309t-a20b36b3d2965b8184abb319f3ddd2ca2398801c0be46321fe6b5f2da97aa9073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cryopreservation</topic><topic>Drug dosages</topic><topic>Endocrine therapy</topic><topic>Fertility</topic><topic>Gender</topic><topic>Gender identity</topic><topic>Hormones</topic><topic>In vitro fertilization</topic><topic>Insurance</topic><topic>International organizations</topic><topic>Motility</topic><topic>Patients</topic><topic>Pregnancy</topic><topic>Preservation</topic><topic>Reproductive health</topic><topic>Reproductive technologies</topic><topic>Sperm</topic><topic>Spermatogenesis</topic><topic>Surgery</topic><topic>Transgender people</topic><topic>Transgender persons</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ainsworth, Alessandra J</creatorcontrib><creatorcontrib>Allyse, Megan</creatorcontrib><creatorcontrib>Khan, Zaraq</creatorcontrib><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ainsworth, Alessandra J</au><au>Allyse, Megan</au><au>Khan, Zaraq</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fertility Preservation for Transgender Individuals: A Review</atitle><jtitle>Mayo Clinic proceedings</jtitle><addtitle>Mayo Clin Proc</addtitle><date>2020-04</date><risdate>2020</risdate><volume>95</volume><issue>4</issue><spage>784</spage><epage>792</epage><pages>784-792</pages><issn>0025-6196</issn><eissn>1942-5546</eissn><abstract>Transgender individuals represent a small, albeit growing, patient population that is encountered more frequently in clinical care due to improved insurance coverage and increasing awareness. Gender-affirming treatments, including both gender-affirming hormone therapy and gender-affirming surgery, pose significant risks to fertility potential and outcomes, ranging from potentially impaired fertility rates to full elimination of reproductive potential depending on the type of treatment pursued. However, there are relatively limited data specific to fertility preservation for transgender individuals. Current approaches to treatment are extrapolated from options for fertility preservation after oncologic diagnoses. In this review, we aim to summarize current clinical approaches, fertility preservation options, and patient experiences in fertility preservation for transgender individuals. Several forms of fertility preservation options are available depending on the pubertal status of a transgender individual. Despite the multiple options for fertility preservation, major barriers exist to patient care and there are reports of mixed patient experiences. Further awareness of this clinical situation and understanding of these processes will allow for comprehensive and specialized care for transgender individuals who may otherwise miss opportunities for adequate counseling or treatment options regarding fertility preservation.</abstract><cop>England</cop><pub>Frontline Medical Communications Inc</pub><pmid>32115195</pmid><doi>10.1016/j.mayocp.2019.10.040</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-6196 |
| ispartof | Mayo Clinic proceedings, 2020-04, Vol.95 (4), p.784-792 |
| issn | 0025-6196 1942-5546 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2369876328 |
| source | Alma/SFX Local Collection |
| subjects | Cryopreservation Drug dosages Endocrine therapy Fertility Gender Gender identity Hormones In vitro fertilization Insurance International organizations Motility Patients Pregnancy Preservation Reproductive health Reproductive technologies Sperm Spermatogenesis Surgery Transgender people Transgender persons |
| title | Fertility Preservation for Transgender Individuals: A Review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T17%3A43%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fertility%20Preservation%20for%20Transgender%20Individuals:%20A%20Review&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=Ainsworth,%20Alessandra%20J&rft.date=2020-04&rft.volume=95&rft.issue=4&rft.spage=784&rft.epage=792&rft.pages=784-792&rft.issn=0025-6196&rft.eissn=1942-5546&rft_id=info:doi/10.1016/j.mayocp.2019.10.040&rft_dat=%3Cgale_proqu%3EA623573481%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2386939089&rft_id=info:pmid/32115195&rft_galeid=A623573481&rfr_iscdi=true |